These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 22581629

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T, Tesar M, Griesel C, Rohde M, Gröne HJ, Waltenberger J, Kollet O, Lapidot T, Yayon A, Weich H.
    Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
    [Abstract] [Full Text] [Related]

  • 5. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H, Rajabibazl M, Ebrahimizadeh W, Dehbidi GR.
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [Abstract] [Full Text] [Related]

  • 6. Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2.
    Miao HQ, Hu K, Jimenez X, Navarro E, Zhang H, Lu D, Ludwig DL, Balderes P, Zhu Z.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):438-45. PubMed ID: 16682007
    [Abstract] [Full Text] [Related]

  • 7. Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.
    Zhang J, Li H, Chen W, Cao P, Wang M.
    Biotechnol Prog; 2009 Jun 23; 25(6):1703-8. PubMed ID: 19731341
    [Abstract] [Full Text] [Related]

  • 8. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD, Wu YY, Tsai YJ, Tsai YS, Lin YY, Lai SL, Huang CY, Lok YY, Hu CY, Lai JS.
    Int J Mol Sci; 2016 Feb 05; 17(2):214. PubMed ID: 26861297
    [Abstract] [Full Text] [Related]

  • 9. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
    Lamdan H, Gavilondo JV, Muñoz Y, Pupo A, Huerta V, Musacchio A, Pérez L, Ayala M, Rojas G, Balint RF, Larrick JW.
    Mol Biosyst; 2013 Aug 05; 9(8):2097-106. PubMed ID: 23702826
    [Abstract] [Full Text] [Related]

  • 10. Isolation of a Novel Anti-KDR3 Single-chain Variable Fragment Antibody from a Phage Display Library.
    Kordi S, Rahmati-Yamchi M, Asghari Vostakolaei M, Etemadie A, Barzegari A, Abdolalizadeh J.
    Iran J Allergy Asthma Immunol; 2019 Jun 08; 18(3):289-299. PubMed ID: 31522436
    [Abstract] [Full Text] [Related]

  • 11. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
    Li H, Cao W, Chen Z, Acheampong DO, Jin H, Li D, Zhang J, Wang M.
    Biomed Pharmacother; 2013 Sep 08; 67(7):599-606. PubMed ID: 23906761
    [Abstract] [Full Text] [Related]

  • 12. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
    Lu D, Shen J, Vil MD, Zhang H, Jimenez X, Bohlen P, Witte L, Zhu Z.
    J Biol Chem; 2003 Oct 31; 278(44):43496-507. PubMed ID: 12917408
    [Abstract] [Full Text] [Related]

  • 13. [Effect of monoclonal antibody against extracellular domain III of vascular endothelial growth factor receptor KDR on proliferation of vascular endothelial cells].
    Li R, Xiong DS, Shao XF, Xu YF, Zhu ZP, Yang CZ.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr 31; 27(4):209-12. PubMed ID: 15949417
    [Abstract] [Full Text] [Related]

  • 14. [Prokaryotic expression and characterization of an anti-KDR single chain antibody].
    Li R, Xiong DS, Xu YF, Shao XF, Fan DM, Zhu ZP, Yang CZ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan 31; 21(1):39-42. PubMed ID: 15629080
    [Abstract] [Full Text] [Related]

  • 15. [Affinity maturation of a single chain antibody against VEGFR2 by hydrophilic shuffling].
    Qi HD, Miao XN, Zhang J, Gu K, Zhang SW, Wang M.
    Yao Xue Xue Bao; 2012 Oct 31; 47(10):1323-8. PubMed ID: 23289144
    [Abstract] [Full Text] [Related]

  • 16. Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor.
    Behdani M, Zeinali S, Khanahmad H, Karimipour M, Asadzadeh N, Azadmanesh K, Khabiri A, Schoonooghe S, Habibi Anbouhi M, Hassanzadeh-Ghassabeh G, Muyldermans S.
    Mol Immunol; 2012 Feb 31; 50(1-2):35-41. PubMed ID: 22208996
    [Abstract] [Full Text] [Related]

  • 17. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 18. Effects of signal sequence on phage-displayed disulfide-stabilized single chain antibody variable fragment (sc-dsFv) libraries.
    Lee YC, Chen IC, Yu CM, Huang YJ, Hsu HJ, Yang AS.
    Biochem Biophys Res Commun; 2011 Jul 29; 411(2):348-53. PubMed ID: 21741355
    [Abstract] [Full Text] [Related]

  • 19. Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library.
    Popkov M, Jendreyko N, Gonzalez-Sapienza G, Mage RG, Rader C, Barbas CF.
    J Immunol Methods; 2004 May 29; 288(1-2):149-64. PubMed ID: 15183093
    [Abstract] [Full Text] [Related]

  • 20. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
    Iyer S, Scotney PD, Nash AD, Ravi Acharya K.
    J Mol Biol; 2006 May 26; 359(1):76-85. PubMed ID: 16616187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.